ArticleNaunyn-Schmiedeberg's archives of pharmacology2017

Differences in the renal antifibrotic cGMP/cGKI-dependent signaling of serelaxin, zaprinast, and their combination.

Veronika Wetzl et al.PubMed ↗Publisher ↗

No numbers read from the abstract.